Combination of Tacalcitol Ointment and Photodynamic Therapy For The Treatment of Follicular Mucinosis of The Scalp.

08:00 EDT 9th July 2019 | BioPortfolio

Summary of "Combination of Tacalcitol Ointment and Photodynamic Therapy For The Treatment of Follicular Mucinosis of The Scalp."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Photodiagnosis and photodynamic therapy
ISSN: 1873-1597


DeepDyve research library

PubMed Articles [23866 Associated PubMed Articles listed on BioPortfolio]

Follicular Induction And CK20+ Merkel Cells Overlying Cutaneous Focal Mucinosis.

Cutaneous focal mucinosis (CFM), or focal dermal mucinosis, is a benign reactive process categorized as a primary mucinosis. Skin biopsy is essential for diagnosis, as the clinical appearance is often...

Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study.

Follicular mucinosis (FM), defined by mucin accumulation within follicular epithelium, may occur in mycosis fungoides (MF). FM without MF is occasionally reported in systemic hematologic malignancies,...

Photodynamic therapy for the treatment of oral squamous carcinoma - clinical implications resulting from in vitro research.

Oral cavity squamous cell carcinoma is a common cancer of the head and neck region. Due to the frequency of diagnoses, high rate of mortality, mutilating nature of classic therapy and numerous complic...

Successful Pregnancy and Delivery Following Selective Use of Photodynamic Therapy in Treatment of the Cervix and Vulva Diseases.

Photodynamic therapy has been gaining popularity, particularly among young women. Therefore it is crucial to evaluate PDT for safety and its impact on fertility and delivery of healthy newborns.

Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.

Field-directed therapy, such as daylight-photodynamic therapy (DL-PDT) or ingenol mebutate (IM), is indicated for multiple actinic keratosis (AK) lesions located on contiguous areas of skin with signi...

Clinical Trials [8119 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds

There are few therapies suitable for the treatment of psoriasis on the face and skin folds. As these areas are sensitive, irritation and other adverse reactions are more common than elsewh...

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris

This study will compare efficacy and safety of once daily treatment of calcipotriol plus betamethasone dipropionate gel (LEO 80185) with tacalcitol ointment and LEO 80185 vehicle alone in ...

Evaluation of Halitosis After Treatment With Photodynamic Therapy Associated With Periodontal Treatment

The aim of this randomized, controlled clinical trial was to treat oral halitosis in healthy adults with photodynamic therapy associated with periodontal treatment and follow them up for 3...

Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK

The aim of this study is to investigate whether PD P 506 A-PDT is effective in treating mild to moderate AK lesions located on the head.

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

To evaluate safety, visual acuity outcomes, persistence of choroidal neovascular leakage, and the number of treatments of combination intravitreal bevacizumab and verteporfin photodynamic ...

Medical and Biotech [MESH] Definitions

The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.

A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis.

Therapy with two or more separate preparations given for a combined effect.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.

Quick Search

DeepDyve research library

Searches Linking to this Article